ENDRA Life Sciences (NASDAQ:NDRA) just reported results for the first quarter of 2024.
- ENDRA Life Sciences reported earnings per share of -26 cents. This was above the analyst estimate for EPS of -27 cents.
- The company did not report any revenue for the quarter.